相关实验视频

Updated: Jun 24, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.4K

基于胰岛素的混合生物材料,用于增强免疫调节反应

Ashok Kumar Jangid1, Kyung Mu Noh1, Sungjun Kim1

  • 1Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea.

Carbohydrate polymers
|June 10, 2024
PubMed
概括

基于益生菌的生物聚合物,特别是胰岛素,通过激活免疫细胞和修改细胞表面来增强对癌症的免疫反应. 这些改性生物聚合物为癌症预防和免疫治疗提供了有前途的战略.

关键词:
果是一种果.混合生物聚合物 混合生物聚合物免疫调节反应的反应.在这种情况下,胰岛素和胰岛素是不同的.

更多相关视频

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research08:48

Author Spotlight: Developing Immunocompetent Organ-on-Chip Models for Infectious Disease Research

Published on: May 24, 2024

1.6K
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

7.3K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.6K